Revolution or Risk? Weighing the Impact of Obesity Drugs on Societal Health

Discover how GLP-1 drugs—game-changing medications like Ozempic and Mounjaro—are reshaping weight management and health care for millions. While their benefits are undeniable, these drugs also raise pressing questions about long-term safety, skyrocketing costs, and unequal access.

In this thought-provoking event, faculty experts will delve into the medical, ethical, and societal implications of GLP-1 drugs. From the role of telehealth and social media in accessibility to the broader challenges of equitable care, this discussion will offer valuable insights for healthcare professionals, policymakers, and anyone curious about the future of obesity treatment.

Don’t miss this opportunity to explore one of the most significant advancements in modern medicine.